Stock analysis, price data, and AI-powered insights for Cigna (CI).
Cigna operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for CI.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). CI Stock Intelligence Report. [stoxpulse.com/stocks/ci]
Disclaimer: The information on this page about Cigna (CI) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Cigna.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings miss
Mar 31
Koka sold 729 shares
Jun 1
Cordani bought 15K shares
May 13
Dividend Champion, Contender, And Challenger Highl...
2d ago
Volatility surge has trader eyeing one 'stable' st...
4d ago
StoxPulse AI results for CI: Pulse Score 65.5/100. Primary sentiment trends from 9 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$78.83B
P/E Ratio
13.3
EPS
$6.26
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
-2.3%
Sep 25
-0.6%
Dec 25
-0.4%
Mar 26
-0.7%
Beat estimates 0 of 4 quarters (0%)
Sector
Healthcare
Industry
Health Care Services
Dividend Champion, Contender, And Challenger Highlights: Week Of June 14
Volatility surge has trader eyeing one 'stable' stock
Options Action: A stable, cash-generating stock to counter the volatility
Mizuho Sees Improved Regulatory Stability, Raises Cigna (CI) Price Objective
CVS Offers A Compelling Turnaround Opportunity Not Seen In Years
Eli Lilly CEO: Obesity-care should be healthcare
Mizuho Maintains Outperform on Cigna Group, Raises Price Target to $340
Is Humana Stock Outperforming the Nasdaq?